|
2016 Conference Publication MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic targetSheng, Yong H., He, Yaowu, Hasnain, Sumaira Z., Wang, Ran, Tong, Hui, Clarke, Daniel T., Lourie, Rohan, Oancea, Lulia, Wong, Kuanyau, Lumley, John W., Florin, Timothy H., Sutton, Philip, Hooper, John. D., Mcmillan, Nigel A. and Mcguckin, Michael A. (2016). MUC13 protects colorectal cancer cells from death by activating the NF-Kb pathway and is a potential therapeutic target. AACR 107th Annual Meeting on Bioinformatics and Systems Biology, New Orleans, Los Angeles, 16-20 April 2016 . Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2016-3564 |
|
2015 Journal Article Cancer stem cell markers in prostate cancer: An immunohistochemical study of ALDH1, SOX2 and EZH2Matsika, Admire, Srinivasan, Bhuvana, Day, Christopher, Mader, Sabina Ann, Kiernan, Deirdre Margaret, Broomfield, Amy, Fu, Jinlin, Hooper, John D., Kench, James G. and Samaratunga, Hemamali (2015). Cancer stem cell markers in prostate cancer: An immunohistochemical study of ALDH1, SOX2 and EZH2. Pathology, 47 (7), 622-628. doi: 10.1097/PAT.0000000000000325 |
|
2015 Conference Publication Potent small agonists of protease activated receptor 2Yau, Mei Kwan, Suen, Jacky, Xu, Weijun, Lim, Junxian, Liu, Ligong, Adams, Mark, He, Yaowu, Hooper, John, Reid, Robert and Fairlie, David (2015). Potent small agonists of protease activated receptor 2. ACS Fall 2015, Boston, MA, United States, 16 - 20 August 2015. Washington, DC, United States: American Chemical Society. |
|
2015 Journal Article Tissue engineered humanized bone supports human hematopoiesis in vivoHolzapfel, Boris M., Hutmacher, Dietmar W., Nowlan, Bianca, Barbier, Valerie, Thibaudeau, Laure, Theodoropoulos, Christina, Hooper, John D., Loessner, Daniela, Clements, Judith A., Russell, Pamela J., Pettit, Allison R., Winkler, Ingrid G. and Levesque, Jean-Pierre (2015). Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials, 61, 103-114. doi: 10.1016/j.biomaterials.2015.04.057 |
|
2015 Journal Article Functional analysis of matriptase-2 mutations and domains: Insights into the molecular basis of iron-refractory iron deficiency anemiaMcDonald, Cameron J., Ostini, Lesa, Bennett, Nigel, Subramaniam, Nanthakumar, Hooper, John, Velasco, Gloria, Wallace, Daniel F. and Nathan Subramaniam, V. (2015). Functional analysis of matriptase-2 mutations and domains: Insights into the molecular basis of iron-refractory iron deficiency anemia. American Journal of Physiology - Cell Physiology, 308 (7), C539-C547. doi: 10.1152/ajpcell.00264.2014 |
|
2015 Journal Article A critical role for murine transferrin receptor 2 in erythropoiesis during iron restrictionWallace, Daniel F., Secondes, Eriza S., Rishi, Gautam, Ostini, Lesa, McDonald, Cameron J., Lane, Steven W., Vu, Therese, Hooper, John D., Velasco, Gloria, Ramsay, Andrew J., Lopez-Otin, Carlos and Subramaniam, V. Nathan (2015). A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction. British Journal of Haematology, 168 (6), 891-901. doi: 10.1111/bjh.13225 |
|
2015 Journal Article Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapyLassemillante, Annie-Claude M., Doi, Suhail A. R., Hooper, John D., Prins, John B. and Wright, Olivia R. L. (2015). Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy. Endocrine, 50 (2), 344-354. doi: 10.1007/s12020-015-0536-7 |
|
2015 Conference Publication EGF-induced recycling of the cancer promoting protein CDCP1Adams, Mark N., Harrington, Brittney S., He, Yaowu, Davies, Claire M., Wallace, Sarah J., Chetty, Naven P., Crandon, Alexander J., Oliveira, Niara B., Shannon, Catherine M., Coward, Jermaine I., Lumley, John W., Perrin, Lewis C., Armes, Jane E. and Hooper, John D. (2015). EGF-induced recycling of the cancer promoting protein CDCP1. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, Germany, June 28th–July 1st, 2014. Dordrecht, Netherlands: Springer Netherlands. doi: 10.1007/s10585-015-9708-3 |
|
2015 Journal Article EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surfaceAdams, M. N., Harrington, B. S., He, Y., Davies, C. M., Wallace, S. J., Chetty, N. P., Crandon, A. J., Oliveira, N. B., Shannon, C. M., Coward, J. I., Lumley, J. W., Perrin, L. C., Armes, J. E. and Hooper, J. D. (2015). EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface. Oncogene, 34 (11), 1375-1383. doi: 10.1038/onc.2014.88 |
|
2014 Journal Article Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidasesDong, Ying, Harrington, Brittney S., Adams, Mark N., Wortmann, Andreas, Stephenson, Sally-Anne, Lisle, Jessica, Herington, Adrian, Hooper, John D. and Clements, Judith A. (2014). Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases. Biological Chemistry, 395 (9), 977-990. doi: 10.1515/hsz-2014-0147 |
|
2014 Journal Article Prevalence of osteoporosis in prostate cancer survivors: a meta-analysisLassemillante, Annie-Claude M., Doi, Suhail A. R, Hooper, John D., Prins, John B. and Wright, Olivia R. L. (2014). Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis. Endocrine, 45 (3), 370-381. doi: 10.1007/s12020-013-0083-z |
|
2014 Conference Publication Investigation of mice deficient in matriptase-2, Hfe and transferrin receptor 2 reveals a novel non-hepatic role for Tfr2 in erythropoiesisWallace, D. F., Secondes, E. S., Rishi, G., Ostini, L., Mcdonald, C. J., Lane, S. W., Hooper, J. D., Lopez-Otin, C. and Subramaniam, V. N. (2014). Investigation of mice deficient in matriptase-2, Hfe and transferrin receptor 2 reveals a novel non-hepatic role for Tfr2 in erythropoiesis. Australian Gastroenterology Week 2014, Broadbeach, Australia, 22-24 October 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12736_6 |
|
2014 Conference Publication A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell CarcinomaHooper, J., He, Y., Wu, A., Harrington, B., Davies, C., Wallace, S., Gilks, B., Perrin, L. and Armes, J. (2014). A New Marker of Poor Outcome and Potential Therapeutic Target in Ovarian Clear Cell Carcinoma. 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, VIC Australia, 8-11 November 2014. London, United Kingdom: Lippincott Williams and Wilkins. doi: 10.1097/01.IGC.0000457075.08973.89 |
|
2014 Journal Article Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell linesBennett, Nigel C., Hooper, John D., Johnson, David W. and Gobe, Glenda C. (2014). Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines. Prostate, 74 (5), 478-487. doi: 10.1002/pros.22767 |
|
2014 Conference Publication Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancerHarrington, B., Davies, C. M., Wallace, S. J., He, Y., Armes, J. E., Perrin, L. C. and Hooper, J. D. (2014). Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer. London, United Kingdom: B M J Group. |
|
2013 Journal Article Alpha-tomatine synergises with paclitaxel to enhance apoptosis of androgen-independent human prostate cancer PC-3 cells in vitro and in vivoLee, Sui-Ting, Wong, Pooi-Fong, Hooper, John David and Mustafa, Mohd Rais (2013). Alpha-tomatine synergises with paclitaxel to enhance apoptosis of androgen-independent human prostate cancer PC-3 cells in vitro and in vivo. Phytomedicine, 20 (14), 1297-1305. doi: 10.1016/j.phymed.2013.07.002 |
|
2013 Conference Publication An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron RestrictionWallace, Daniel F., McDonald, Cameron J., Secondes, Eriza S., Ostini, Lesa, Rishi, Gautam, Hooper, John D., Velasco, Gloria, Ramsay, Andrew J., Lopez-Otin, Carlos and Subramaniam, V. Nathan (2013). An Essential Role For Transferrin Receptor 2 In Erythropoiesis During Iron Restriction. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2013 Journal Article Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B SignalingLee, Sui-Ting, Wong, Pooi-Fong, He, Hui, Hooper, John David and Mustafa, Mohd Rais (2013). Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling. PLoS One, 8 (2), e57708-e57708. doi: 10.1371/journal.pone.0057708 |
|
2013 Book Chapter Matriptase-2Ramsay, Andrew J., Kwarciak, Agnieszka, Hooper, John D., Lopez-Otin, Carlos and Velasco, Gloria (2013). Matriptase-2. Handbook of proteolytic enzymes. (pp. 2975-2983) edited by Neil D. Rawlings and Guy Salvensen. London, United Kingdom: Academic Press. doi: 10.1016/B978-0-12-382219-2.00650-5 |
|
2013 Conference Publication Clinically Identified Tmprss6 Mutations Result in Either Trafficking Defects or Inability to Cleave HemojuvelinBennett, Nigel C., McDonald, Cameron J., Wallace, Daniel F., Hooper, John D., Lopez-Otin, Carlos and Subramaniam, V. Nathan (2013). Clinically Identified Tmprss6 Mutations Result in Either Trafficking Defects or Inability to Cleave Hemojuvelin. BioIron 2013: 5th Meeting of the International BioIron Society, University College London UK, April 14 – 18, 2013. Hoboken, United States: Jossey Bass, Ed. & Pub.. doi: 10.1002/ajh.23453 |
